ADDEX THERAP. SF 0,01 revenue breakdown overview

ADDEX THERAP. SF 0,01 revenue for the last year amounted to 1.60 M EUR, the most of which — 436.13 k EUR — came from its highest performing source at the moment, Small-molecule Pharmaceutical Products, the year earlier bringing 1.77 M EUR. The greatest contribution to the revenue figure was made by Switzerland — last year it brought ADDEX THERAP. SF 0,01 436.13 k EUR, and the year before that — 1.77 M EUR.